PRESS RELEASE published on 10/30/2024 at 19:00, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce ses résultats financiers du premier semestre 2024, avec des avancées majeures sur ses priorités de 2023-2024. Les études pour l'accès au marché américain et le développement produit SONOVEIN® sont au cœur de sa stratégie Résultats Financiers Marché Américain Theraclion SONOVEIN Développement Produit
BRIEF published on 09/06/2024 at 18:35, 1 year 8 months ago Theraclion presents its achievements for the first half of 2024 FDA China R&D Theraclion SONOVEIN®
BRIEF published on 09/06/2024 at 18:35, 1 year 8 months ago Theraclion présente ses réalisations du premier semestre 2024 FDA R&D Chine Theraclion SONOVEIN®
PRESS RELEASE published on 09/06/2024 at 18:30, 1 year 8 months ago Inside Information / Other news releases Theraclion reports strong mid-year achievements focusing on U.S. market access, R&D progress, and Chinese market entry. Key milestones include FDA pivotal study completion and international scientific recognition FDA China R&D Theraclion Achievements
PRESS RELEASE published on 09/06/2024 at 18:30, 1 year 8 months ago Informations privilégiées / Autres communiqués Theraclion confirme ses réalisations du premier semestre 2024, incluant l'étude pivot de la FDA, progrès en R&D et marché chinois FDA R&D Chine Theraclion SONOVEIN®
Published on 05/08/2026 at 15:55, 20 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 1 hour 15 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 1 hour 20 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 1 hour 45 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 2 hours 15 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 16:05, 10 minutes ago ANTHBOT Announces Marc ter Stegen as Global Brand Ambassador
Published on 05/08/2026 at 15:32, 42 minutes ago EQS-Adhoc: The Management Board and Supervisory Board of 11880 Solutions AG approve a proposal for a 5:1 share capital reduction
Published on 05/08/2026 at 15:26, 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/07/2026 at 19:15, 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 21 hours 9 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 21 hours 9 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 21 hours 15 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
